China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.31
(-0.86%)
HKD 2.31
(-0.86%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 13.13 Billion CNY | 3.62% |
| 2022 | 12.67 Billion CNY | -7.68% |
| 2021 | 13.72 Billion CNY | 12.6% |
| 2020 | 12.19 Billion CNY | -9.17% |
| 2019 | 13.42 Billion CNY | 5.06% |
| 2018 | 12.77 Billion CNY | 15.42% |
| 2017 | 11.07 Billion CNY | 33.68% |
| 2016 | 8.28 Billion CNY | 29.56% |
| 2015 | 6.39 Billion CNY | 208.06% |
| 2014 | 2.07 Billion CNY | -7.03% |
| 2013 | 2.23 Billion CNY | 217.22% |
| 2012 | 703.52 Million CNY | 32.02% |
| 2011 | 532.88 Million CNY | 12.26% |
| 2010 | 474.68 Million CNY | 62.85% |
| 2009 | 291.49 Million CNY | 122.77% |
| 2008 | 130.84 Million CNY | 3.75% |
| 2007 | 126.11 Million CNY | -21.73% |
| 2006 | 161.13 Million CNY | -72.44% |
| 2005 | 584.66 Million CNY | 0.18% |
| 2004 | 583.59 Million CNY | -7.36% |
| 2003 | 629.94 Million CNY | -14.14% |
| 2002 | 733.69 Million CNY | -7.99% |
| 2001 | 797.42 Million CNY | -4.87% |
| 2000 | 838.26 Million CNY | -20.36% |
| 1999 | 1.05 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 13.39 Billion CNY | 2.01% |
| 2024 Q2 | 13.39 Billion CNY | 0.0% |
| 2023 Q3 | 13.13 Billion CNY | -12.89% |
| 2023 Q4 | 13.13 Billion CNY | 0.0% |
| 2023 FY | 13.13 Billion CNY | 3.62% |
| 2023 Q2 | 15.07 Billion CNY | 0.0% |
| 2023 Q1 | 15.07 Billion CNY | 18.95% |
| 2022 Q1 | 15.18 Billion CNY | 10.64% |
| 2022 Q3 | 12.68 Billion CNY | -16.46% |
| 2022 Q4 | 12.67 Billion CNY | -0.12% |
| 2022 FY | 12.67 Billion CNY | -7.68% |
| 2022 Q2 | 15.18 Billion CNY | 0.0% |
| 2021 Q4 | 13.72 Billion CNY | 0.0% |
| 2021 Q1 | 13.69 Billion CNY | 12.3% |
| 2021 Q3 | 13.72 Billion CNY | 0.27% |
| 2021 Q2 | 13.69 Billion CNY | 0.0% |
| 2021 FY | 13.72 Billion CNY | 12.6% |
| 2020 Q2 | 14.19 Billion CNY | 0.0% |
| 2020 Q4 | 12.19 Billion CNY | 0.0% |
| 2020 FY | 12.19 Billion CNY | -9.17% |
| 2020 Q1 | 14.19 Billion CNY | 5.73% |
| 2020 Q3 | 12.19 Billion CNY | -14.09% |
| 2019 Q2 | 13.1 Billion CNY | 0.0% |
| 2019 Q4 | 13.42 Billion CNY | 0.0% |
| 2019 Q3 | 13.42 Billion CNY | 2.41% |
| 2019 Q1 | 13.1 Billion CNY | 2.59% |
| 2019 FY | 13.42 Billion CNY | 5.06% |
| 2018 Q4 | 12.77 Billion CNY | 0.0% |
| 2018 Q1 | 11.64 Billion CNY | 5.15% |
| 2018 FY | 12.77 Billion CNY | 15.42% |
| 2018 Q2 | 11.64 Billion CNY | 0.0% |
| 2018 Q3 | 12.77 Billion CNY | 9.76% |
| 2017 Q4 | 11.07 Billion CNY | 0.0% |
| 2017 Q1 | 9.85 Billion CNY | 19.01% |
| 2017 Q3 | 11.07 Billion CNY | 12.33% |
| 2017 FY | 11.07 Billion CNY | 33.68% |
| 2017 Q2 | 9.85 Billion CNY | 0.0% |
| 2016 Q3 | 8.28 Billion CNY | 24.78% |
| 2016 Q2 | 6.63 Billion CNY | 35.86% |
| 2016 Q1 | 4.88 Billion CNY | -23.57% |
| 2016 Q4 | 8.28 Billion CNY | 0.0% |
| 2016 FY | 8.28 Billion CNY | 29.56% |
| 2015 Q2 | 2.38 Billion CNY | 0.0% |
| 2015 Q4 | 6.39 Billion CNY | -9.58% |
| 2015 FY | 6.39 Billion CNY | 208.06% |
| 2015 Q3 | 7.06 Billion CNY | 196.97% |
| 2015 Q1 | 2.38 Billion CNY | 14.72% |
| 2014 Q2 | 2.17 Billion CNY | 0.0% |
| 2014 FY | 2.07 Billion CNY | -7.03% |
| 2014 Q4 | 2.07 Billion CNY | 0.0% |
| 2014 Q1 | 2.17 Billion CNY | -2.55% |
| 2014 Q3 | 2.07 Billion CNY | -4.6% |
| 2013 Q3 | 2.23 Billion CNY | 190.92% |
| 2013 FY | 2.23 Billion CNY | 217.22% |
| 2013 Q4 | 2.23 Billion CNY | 0.0% |
| 2013 Q2 | 767.12 Million CNY | 7.65% |
| 2013 Q1 | 712.6 Million CNY | 1.29% |
| 2012 Q3 | 649.25 Million CNY | -3.74% |
| 2012 FY | 703.52 Million CNY | 32.02% |
| 2012 Q2 | 674.5 Million CNY | 0.0% |
| 2012 Q4 | 703.52 Million CNY | 8.36% |
| 2011 Q4 | 532.88 Million CNY | 0.0% |
| 2011 Q2 | 447.01 Million CNY | 0.0% |
| 2011 FY | 532.88 Million CNY | 12.26% |
| 2010 Q4 | 474.68 Million CNY | 0.0% |
| 2010 FY | 474.68 Million CNY | 62.85% |
| 2010 Q2 | 282.29 Million CNY | 0.0% |
| 2009 Q4 | 291.49 Million CNY | 0.0% |
| 2009 FY | 291.49 Million CNY | 122.77% |
| 2009 Q2 | 266.62 Million CNY | 0.0% |
| 2008 FY | 130.84 Million CNY | 3.75% |
| 2008 Q4 | 130.84 Million CNY | 0.0% |
| 2007 FY | 126.11 Million CNY | -21.73% |
| 2006 FY | 161.13 Million CNY | -72.44% |
| 2005 FY | 584.66 Million CNY | 0.18% |
| 2004 FY | 583.59 Million CNY | -7.36% |
| 2003 FY | 629.94 Million CNY | -14.14% |
| 2002 FY | 733.69 Million CNY | -7.99% |
| 2001 FY | 797.42 Million CNY | -4.87% |
| 2000 FY | 838.26 Million CNY | -20.36% |
| 1999 FY | 1.05 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 142.28 Million HKD | -9129.369% |
| Grand Pharmaceutical Group Limited | 7.24 Billion HKD | -81.257% |
| Extrawell Pharmaceutical Holdings Limited | 170.4 Million HKD | -7606.098% |
| Wai Yuen Tong Medicine Holdings Limited | 709.65 Million HKD | -1750.441% |
| Qianhai Health Holdings Limited | 94 Million HKD | -13869.48% |
| Lee's Pharmaceutical Holdings Limited | 930.06 Million HKD | -1311.909% |
| Essex Bio-Technology Limited | 903.78 Million HKD | -1352.977% |
| Tongfang Kontafarma Holdings Limited | 665.38 Million HKD | -1873.542% |
| PuraPharm Corporation Limited | 689.65 Million HKD | -1804.112% |
| SSY Group Limited | 4.49 Billion HKD | -192.21% |
| JBM (Healthcare) Limited | 366.75 Million HKD | -3480.538% |
| Jacobson Pharma Corporation Limited | 1.09 Billion HKD | -1104.2% |
| China Resources Pharmaceutical Group Limited | 168.46 Billion HKD | 92.205% |